TrianglePartial Breast Irradiation (NCT07654257)
Partial Breast Irradiation trial for Breast Cancer (NCT07654257). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for women aged 40–85 with newly diagnosed DCIS or invasive breast cancer after lumpectomy with clear margins. Tumor size and lymph-node rules apply; prior neoadjuvant chemotherapy is excluded.
The idea: deliver radiation to part of the breast through multiple implanted catheters, in one 16-gray treatment over one day. Researchers assess toxicity against earlier trials. HER2-positive patients must plan or have received HER2-directed therapy.
This phase 2 study plans 134 patients. Bridget Quinn leads at Virginia Commonwealth University in Richmond, the sole recruiting US site.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.